|
|
Volumn 30, Issue 4, 1998, Pages 1331-1332
|
|
Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
DACLIZUMAB;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COVALENT BOND;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INCIDENCE;
MAJOR CLINICAL STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR AFFINITY;
|
|
EID: 0031803562
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00264-4 Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (0)
|
